Evidence map›Paper›PMID 30661122›Full record

ReviewCurrent cardiology reports2019

Is Hemispheric Hypoperfusion a Treatable Cause of Cognitive Impairment?

Amani M Norling, Randolph S Marshall, Marykay A Pavol, George Howard, Virginia Howard, David Liebeskind, John Huston, Brajesh K Lal, Thomas G Brott, Ronald M Lazar

Open access · greenAbstract readReview
In one paragraph

Review in Current cardiology reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Hemodynamic impairments within individual watershed areas in asymptomatic carotid artery stenosis by multimodal MRI.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2021
    Article
  9. Poststroke Montreal Cognitive Assessment and Recurrent Stroke in Patients With Symptomatic Intracranial Atherosclerosis.Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association · 2020
    Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 1 country.

Amani M NorlingDepartment of Neurology, University of Alabama at Birmingham, 1720 7th Ave S-SC 650, Birmingham, AL, 35294, USA.
Randolph S MarshallDepartment of Neurology, Columbia University Medical Center, New York, NY, USA.
Marykay A PavolDepartment of Neurology, Columbia University Medical Center, New York, NY, USA.
George HowardDepartment of Biostatistics (GH), University of Alabama at Birmingham, Birmingham, AL, USA.
Virginia HowardDepartment of Epidemiology (VH), University of Alabama at Birmingham, Birmingham, AL, USA.
David LiebeskindDepartment of Neurology, University of California, Los Angeles, CA, USA.
John HustonDepartment of Neuroradiology (JH), Mayo Clinic, Rochester, MN, USA.
Brajesh K LalDepartment of Vascular Surgery (BKL), University of Maryland, Baltimore, MD, USA.
Thomas G BrottDepartment of Neurology, Mayo Clinic, Jacksonville, FL, USA.
Ronald M LazarDepartment of Neurology, University of Alabama at Birmingham, 1720 7th Ave S-SC 650, Birmingham, AL, 35294, USA. rlazar@uabmc.edu.
University of Alabama at Birmingham · USColumbia University Irving Medical Center · USMayo Clinic · USUniversity of California, Los Angeles · USUniversity of Maryland, Baltimore · USWinnMed · US

Funding

CREST-2 Clinical Coordinating CenterU01NS080168 · NINDS · MAYO CLINIC JACKSONVILLE · PI Thomas G Brott, JAMES F MESCHIA · 2014 to 2026
$56.3M
CREST-2 Statistical and Data Coordinating Center - SDCCU01NS080165 · NINDS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI EDWARDS, LLOYD J · 2014 to 2025
$15.0M
Carotid Revascularization and Medical Management for Asymptomatic CarotidStenosis Trial - Hemodynamics (CREST-H)R01NS097876 · NINDS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI RONALD M LAZAR, DAVID SIGMUND LIEBESKIND · 2017 to 2026
$6.4M
StrokeBelt StrokeNetU24NS107223 · NINDS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Toby Gropen, Mark Robert Harrigan · 2018 to 2026
$2.6M
New York Stroke Trials Network of Columbia and Cornell (NYCCSTN)U10NS086728 · NINDS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI MARSHALL, RANDOLPH S · 2013 to 2017
$2.0M
UAB Predoctoral Training Grant in Translational and Molecular SciencesT32GM109780 · NIGMS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI PATEL, RAKESH P. · 2015 to 2019
$967k
NIGMS NIH HHS T32 GM109780NINDS NIH HHS R01 NS097876NINDS NIH HHS U01 NS080165NINDS NIH HHS U01 NS080168NINDS NIH HHS U10 NS086728NINDS NIH HHS U24 NS107223
6 · The paper itself

Abstract

purpose of reviewTo review the current literature that supports the notion that cerebral hemodynamic compromise from internal carotid artery stenosis may be a cause of vascular cognitive impairment that is amenable to treatment by revascularization. RECENT

findingsConverging evidence suggests that successful carotid endarterectomy and carotid artery stenting are associated with reversal of cognitive decline in many patients with severe but asymptomatic carotid artery stenosis. Most of these findings have been derived from cohort studies and comparisons with either normal or surgical controls. Failure to find treatment benefit in a number of studies appears to have been the result of patient heterogeneity or confounding from concomitant conditions independently associated with cognitive decline, such as heart failure and other cardiovascular risk factors, or failure to establish pre-procedure hemodynamic failure. Patients with severe carotid artery stenosis causing cerebral hemodynamic impairment may have a reversible cause of cognitive decline. None of the prior studies, however, were done in the context of a randomized clinical trial with large numbers of participants. The ongoing CREST-2 trial comparing revascularization with medical therapy versus medical therapy alone, and its associated CREST-H study determining whether cognitive decline is reversible among those with hemodynamic compromise may address this question.

Indexed as

Endarterectomy, CarotidStentsBlood Vessel Prosthesis ImplantationBrainCarotid ArteriesCarotid StenosisCognitionCognitive DysfunctionHumansRisk FactorsTreatment OutcomeCarotid artery stentingCarotid endarterectomyCerebral hemodynamic impairmentCognitionRevascularizationSevere carotid artery stenosis

Identifiers

PMID30661122
PMCPMC8985657
OpenAlexW2909436281

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.